Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Cash from Discontinued Operations (2009 - 2026)

Revvity's (RVTY) quarterly Cash from Discontinued Operations came in at -$10.7 million in Q2 2026, down 79.35% on a YoY basis from -$51.6 million in Q2 2025, and down 13056.79% quarter-over-quarter from -$81000.0 in Q3 2025.

Analysis

Revvity (RVTY) Cash from Discontinued Operations (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Cash from Discontinued Operations for 16 consecutive years, with -$10.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Discontinued Operations fell 79.35% year-over-year to -$10.7 million; the trailing twelve-month figure through Jul 2026 stood at -$10.7 million (up 34.16% YoY), and the FY2025 full-year result was -$6.0 million, up 83.57% from the prior year.
  • Cash from Discontinued Operations eased to -$10.7 million in Q2 2026 per RVTY's latest filing, from -$81000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at -$81000.0 in Q3 2025 and bottomed at -$91.7 million in Q3 2023.
  • Historically, Cash from Discontinued Operations has averaged -$27.5 million across 5 years, with a median of -$10.7 million in 2026.
  • The widest YoY moves for Cash from Discontinued Operations: up 99.11% in 2025, down 130.04% in 2025.
  • Over 5 years, Cash from Discontinued Operations stood at -$42.9 million in 2022, then soared by 44.08% to -$24.0 million in 2023, then soared by 94.84% to -$1.2 million in 2024, then surged by 93.45% to -$81000.0 in 2025, then sank by 13056.79% to -$10.7 million in 2026.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods registered -$10.7 million, -$81000.0, and -$5.9 million for Q2 2026, Q3 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 5, 2026 -10.66 Mn
Sep 28, 2025 -81,000.00
Mar 30, 2025 -5.94 Mn
Dec 29, 2024 -1.24 Mn
Sep 29, 2024 -9.13 Mn
Jun 30, 2024 -23.71 Mn
Mar 31, 2024 -2.58 Mn
Dec 31, 2023 -23.99 Mn
Oct 1, 2023 -64.24 Mn
Jul 2, 2023 -91.67 Mn
Apr 2, 2023 -8.21 Mn
Jan 1, 2023 -73.37 Mn
Apr 3, 2022 -42.91 Mn
Jan 3, 2021 187.46 Mn
Sep 30, 2018 -200,000.00
Dec 31, 2017 1.10 Mn
Oct 1, 2017 -11.01 Mn
Jul 2, 2017 -6.33 Mn
Apr 2, 2017 12.53 Mn
Jan 1, 2017 26.91 Mn